Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shiangtung Jung
Institution:
Ionis Pharmaceuticals (United States)
Observed institution:
Ionis Pharmaceuticals (United States)
OpenAlex ID:
A5137914967
Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermedia
2026
·
Ali Taher
, Michael D Diamantidis
, et al.
·
Blood Advances
·
4
Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera
2026
·
Jeanne M Palmer
, Jonathan How
, et al.
·
Blood
Show more works
View as search
Works count:
2
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type
